Open Heart Surgery News and Research

RSS

Endotis commences EP217609 Phase IIa study in patients undergoing open-heart surgery

Endotis Pharma, a world leader in the development of neutralizable anticoagulants, today announced enrolment of the first patients into a Phase IIa study using EP217609 and its specific antidote avidin to manage coagulation during open-heart surgery.

22 Jun 2011

Black patients with heart attack wait longer at hospitals to get life-saving procedures

Black patients having a heart attack wait longer at hospitals than white patients to get advanced procedures that will restore blood flow to their hearts, according to a University of Michigan Health System study.

21 Jun 2011

Hardin Memorial Hospital selects ProVation Order Sets

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Hardin Memorial Hospital has selected ProVation® Order Sets, powered by UpToDate® Decision Support, as the organization's electronic order set solution.

20 Jun 2011

First human implant of St. Jude Medical's Portico transcatheter aortic heart valve

St. Jude Medical, Inc., a global medical device company, today announced the first human implant of its Portico transcatheter aortic heart valve. The procedure was performed by Dr. John Webb, director of cardiac catheterization and interventional cardiology at St. Paul's Hospital in Vancouver, British Columbia.

7 Jun 2011

Mount Sinai to participate in Medtronic CoreValve U.S. Clinical Trial

Mount Sinai Medical Center in Miami Beach, Florida announced its participation in the Medtronic CoreValve U.S. Clinical Trial, which will evaluate a new, non-surgical alternative to open-heart surgery for patients with severe aortic stenosis. Mount Sinai is now among a select number of leading hospitals across the U.S. to participate in this trial.

From Medtronic 4 Jun 2011

U-M study shows decline in surgery mortality for eight different high-risk operations

Surgery death rates have dropped nationwide over the past decade, according to a University of Michigan Health System study that reveals cancer surgeries have seen the most dramatic improvement in safety.

3 Jun 2011

New hybrid OR at Loyola equipped with advanced fluoroscopy equipment

Loyola University Medical Center has opened a hybrid operating room that combines the imaging capabilities of a cardiac catheterization lab with the sterile environment of a conventional operating room (OR).

23 May 2011

Meta-analysis confirms positive outcomes in patients implanted with Medtronic CoreValve System

A late-breaking presentation about transcatheter aortic valve implantation (TAVI) at EuroPCR 2011 today confirmed positive outcomes in patients receiving the CoreValve System from Medtronic, Inc. across seven international clinical registries.

From Medtronic 20 May 2011

Medtronic issues statement on results of CoreValve System clinical data presented at EuroPCR 2011

Medtronic, Inc. today issued a statement on results of clinical data presented at EuroPCR 2011 that show the Medtronic CoreValve System, delivered through a new approach beneath the collarbone, achieved excellent procedural success rates and low in-hospital complication rates.

From Medtronic 19 May 2011

Washington Post examines Iraq's Baghdad Hospital

In an article looking at Baghdad Hospital, the Washington Post reports that "[i]t is difficult to overstate how far [the hospital] has come since the worst days of the war, when supplies were so scarce that doctors sometimes performed open heart surgery without gloves. ... Arriving at work was a small miracle: The hospital has lost at least 40 doctors to assassins since 2004 - they are still occasionally targeted - and their photos stare down from walls."

11 May 2011

MAQUET introduces new pediatric oxygenators and reservoirs in the U.S.

MAQUET Cardiovascular today announced the launch of its QUADROX-i Neonatal and Pediatric oxygenators and reservoirs in the United States. Oxygenators are an integral part of a cardiopulmonary bypass system and function as an artificial lung during surgical procedures.

27 Apr 2011

FDA approves St. Jude Medical's Trifecta valve for stented aortic valve replacement

St. Jude Medical, Inc., a global medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) approval for its Trifecta™ valve. The valve, a clinically-proven replacement for diseased, damaged or malfunctioning aortic heart valves, mimics the flow of a natural, healthy heart and represents a significant new product in the pericardial aortic stented tissue valve market.

21 Apr 2011

Loyola enrolls patients in clinical trial for open-heart valve replacement surgery

Loyola University Hospital is enrolling patients in a clinical trial that offers an alternative to traditional open-heart surgery for patients who need new aortic heart valves.

20 Apr 2011

MR patients treated with Abbott MitraClip system demonstrate clinical benefits of initial treatment at two years

Abbott today announced data from its EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) study showing that patients with significant mitral regurgitation (MR) treated with the company's investigational percutaneous catheter-based MitraClip® system continue to demonstrate the clinical benefits of initial treatment shown at one year out to two years, including improvements in heart function and reductions in symptoms.

5 Apr 2011

Less-invasive catheter-based aortic valve replacement as safe and effective as open surgery

Less-invasive catheter-based aortic valve replacement has a similar one-year survival as open valve-replacement surgery for patients at high risk for surgery.

5 Apr 2011

The New England Journal of Medicine publishes positive results from NorthShore's EVEREST II trial

NorthShore University HealthSystem interventional cardiologist, Ted Feldman, MD, presented positive results from the EVEREST II trial, that were concurrently published in The New England Journal of Medicine.

5 Apr 2011

Non-invasive catheterization can lead to positive outcomes in elderly patients with stenosis

A major new study presented today at the yearly scientific meeting of the American College of Cardiology (ACC) in New Orleans shows conclusively that replacing defective aortic valves in elderly patients through non-invasive "catheterization" – rather than through much more invasive open-heart surgery – leads to significantly better outcomes.

4 Apr 2011

SMT announces $10.5 million financing to develop novel device for use in TAVI procedures

SMT Research and Development Ltd. of Herzliya Pituach, Israel announced today a significant investment by OrbiMed Advisors LLC. SMT is finalizing the development of a novel embolic protection device designed for use during Transcatheter Aortic Valve Implantation procedures.

4 Apr 2011

Regado's REG1 system Phase 2b trial results presented at i2 Summit

Regado Biosciences, Inc., a privately held company pioneering the development of antithrombotic aptamers with active control agents, announced today the primary results of the RADAR Phase 2b clinical trial of the company's lead product, the anticoagulation system REG1, at the i2 Summit during the American College of Cardiology 2011 60th Annual Scientific Session & Expo in New Orleans, LA.

4 Apr 2011

New heart valve procedure helpful for the elderly: Study

Researchers revealed this Sunday a new heart valve that can be implanted without surgery. The device may hold promise for tens of thousands of elderly patients who might not survive a standard valve-replacement operation.

3 Apr 2011

Open Heart Surgery News and Research

Endotis commences EP217609 Phase IIa study in patients undergoing open-heart surgery

Black patients with heart attack wait longer at hospitals to get life-saving procedures

Hardin Memorial Hospital selects ProVation Order Sets

First human implant of St. Jude Medical's Portico transcatheter aortic heart valve

Mount Sinai to participate in Medtronic CoreValve U.S. Clinical Trial

U-M study shows decline in surgery mortality for eight different high-risk operations

New hybrid OR at Loyola equipped with advanced fluoroscopy equipment

Meta-analysis confirms positive outcomes in patients implanted with Medtronic CoreValve System

Medtronic issues statement on results of CoreValve System clinical data presented at EuroPCR 2011

Washington Post examines Iraq's Baghdad Hospital

MAQUET introduces new pediatric oxygenators and reservoirs in the U.S.

FDA approves St. Jude Medical's Trifecta valve for stented aortic valve replacement

Loyola enrolls patients in clinical trial for open-heart valve replacement surgery

MR patients treated with Abbott MitraClip system demonstrate clinical benefits of initial treatment at two years

Less-invasive catheter-based aortic valve replacement as safe and effective as open surgery

The New England Journal of Medicine publishes positive results from NorthShore's EVEREST II trial

Non-invasive catheterization can lead to positive outcomes in elderly patients with stenosis

SMT announces $10.5 million financing to develop novel device for use in TAVI procedures

Regado's REG1 system Phase 2b trial results presented at i2 Summit

New heart valve procedure helpful for the elderly: Study

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News